Starts in:

By Matt Harrington, BCBA · Behaviorist Book Club · Clinical decision guide

Behavioral vs. Medical Models of Chronic Pain: Clinical Implications for ABA Practice

In This Guide
  1. Side-by-Side Comparison
  2. Clinical Decision Framework
  3. Key Takeaways

One of the most consequential decisions a behavior analyst makes is not just what intervention to use, but how to approach the clinical question in the first place. For pelvicon vulvodynia symposium 2024 - dr. jill krapf - medical management of vulvodynia, the difference between an evidence-based, individualized approach and a traditional, protocol-driven one can significantly impact outcomes.

This guide lays out the key factors side by side to support your clinical decision-making.

Side-by-Side Comparison

Factor Evidence-Based Approach Traditional Approach
Primary causal explanation Biomedical model: pain is caused by tissue damage or nociceptive pathology; treatment targets the injury or disease Behavioral model: pain behaviors are shaped and maintained by operant learning contingencies; behavioral antecedents and consequences are clinical targets
Role of avoidance Biomedical model: activity restriction is appropriate protection against further tissue damage; pain is a guide to activity limits Behavioral model: generalized avoidance beyond what is medically necessary is a learned behavior maintained by short-term negative reinforcement, producing long-term disability
Treatment targets Biomedical model: reduce nociceptive input through medication, surgery, or physical intervention Behavioral model: increase activity engagement despite pain, reduce pain behavior reinforcement, build valued life functioning
Role of communication Biomedical model: pain reports are signals to the medical team about tissue status; maximizing accurate reporting is the goal Behavioral model: pain reports and pain behaviors are operant responses shaped by their consequences; reinforcement history is relevant to their interpretation
Appropriate BCBA scope Biomedical model: BCBA scope is limited — medical management is primary, behavioral contribution is supplementary Behavioral model: BCBA has direct clinical contribution through functional assessment of pain behaviors, activity engagement programming, and coordination with multidisciplinary team
Outcome definition Biomedical model: pain reduction is the primary outcome; functional improvement is secondary Behavioral model: functional engagement and quality of life are primary outcomes; pain reduction enhances but does not gatekeep functional improvement
FREE CEUs

Get CEUs on This Topic — Free

The ABA Clubhouse has 60+ on-demand CEUs including ethics, supervision, and clinical topics like this one. Plus a new live CEU every Wednesday.

60+ on-demand CEUs (ethics, supervision, general)
New live CEU every Wednesday
Community of 500+ BCBAs
100% free to join
Join The ABA Clubhouse — Free →

Clinical Decision Framework

Use this framework when approaching pelvicon vulvodynia symposium 2024 - dr. jill krapf - medical management of vulvodynia in your practice:

Step 1: Is intervention warranted?

Does the data support a need for intervention? Is there a meaningful impact on the individual's quality of life, safety, or access to reinforcement?

YES → Proceed to assessment NO → Document reasoning, monitor

Step 2: Have you conducted an individualized assessment?

A functional assessment should guide intervention selection. Avoid defaulting to standard protocols without individual analysis. Consider environmental variables, setting events, and private events.

YES → Select evidence-based approach matched to function NO → Complete assessment first

Step 3: Is the individual/caregiver involved in decision-making?

Goals should be co-developed. Assent and informed consent are ethical requirements. The individual's preferences and values matter in selecting both goals and methods.

YES → Proceed with collaborative plan NO → Engage in shared decision-making

Step 4: Verify your approach

Key Takeaways

Go Deeper With This CEU

This course covers the clinical and ethical dimensions in detail with structured learning objectives and CEU credit.

Pelvicon Vulvodynia Symposium 2024 - Dr. Jill Krapf - Medical Management of Vulvodynia — Jessica Reale · 1 BACB General CEUs · $0

Take This Course →
📚 Browse All 60+ Free CEUs — ethics, supervision & clinical topics in The ABA Clubhouse

Related

CEU Course: Pelvicon Vulvodynia Symposium 2024 - Dr. Jill Krapf - Medical Management of Vulvodynia

1 BACB General CEUs · $0 · BehaviorLive

Guide: Pelvicon Vulvodynia Symposium 2024 - Dr. Jill Krapf - Medical Management of Vulvodynia — What Every BCBA Needs to Know

Research-backed educational guide

FAQ: 10 Questions About Pelvicon Vulvodynia Symposium 2024 - Dr. Jill Krapf - Medical Management of Vulvodynia

Research-backed answers for behavior analysts

Clinical Disclaimer

All behavior-analytic intervention is individualized. The information on this page is for educational purposes and does not constitute clinical advice. Treatment decisions should be informed by the best available published research, individualized assessment, and obtained with the informed consent of the client or their legal guardian. Behavior analysts are responsible for practicing within the boundaries of their competence and adhering to the BACB Ethics Code for Behavior Analysts.

60+ Free CEUs — ethics, supervision & clinical topics